StockWatch
·

Concord Biotech Ltd Q3 FY25 Results

CONCORDBIOQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue244.2221.3%
Total Income258.9519.1%
Expenditure159.6314.6%
PBT99.3225.5%
Net Profit75.9220.7%
OPM29.17%6.25pp
NPM28.61%2.21pp
EPS7.2620.7%
View full financials

Informational and educational content only. Not investment advice.